Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Leah Noëmi Cueni has worked on the following 13 EPO patent applications which have been published in the last five years:

EP12755967

BISPECIFIC ANTIGEN BINDING MOLECULES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12778018

IMPROVED ASSEMBLY OF BISPECIFIC ANTIBODIES

IPC classification:
C07K 16/46
Applicant:
F. Hoffmann-La Roche AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP12772787

SEPARATION METHOD FOR FUCOSYLATED ANTIBODIES

IPC classification:
C07K 1/22, C07K 14/705, C07K 16/00
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13745096

COMPOSITION COMPRISING TWO ANTIBODIES ENGINEERED TO HAVE REDUCED AND INCREASED EFFECTOR FUNCTION

IPC classification:
A61K 47/48, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/32, C07K 16/40
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13745407

INTERLEUKIN-10 FUSION PROTEINS AND USES THEREOF

IPC classification:
C07K 14/54, C07K 16/18, C07K 19/00
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13745419

ASGPR ANTIBODIES AND USES THEREOF

IPC classification:
A61K 38/19, A61P 31/14, A61P 35/00, C07K 16/28
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13745844

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

IPC classification:
A61K 38/20, A61K 47/48, A61K 51/10, C07K 14/55, C12N 15/62
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14708507

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14705788

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IPC classification:
A61K 35/00, A61K 39/395, C07K 16/28, C07K 16/30, C07K 16/46
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP16164244

MUTANT INTERLEUKIN-2 POLYPEPTIDES

IPC classification:
A61K 38/20, A61K 39/00, A61K 39/395, A61K 47/48, C07K 14/54, C07K 14/55, C07K 16/30, C07K 16/40, C07K 16/46, C07K 19/00, C12N 15/26
Applicant:
Roche Glycart AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15709419

INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF

IPC classification:
C07K 14/55, C07K 16/46, C07K 19/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15701991

INTERLEUKINE 10 IMMUNOCONJUGATES

IPC classification:
C07K 14/54, C12N 15/62
Applicant:
F. Hoffmann-La Roche AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15753700

COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1

IPC classification:
A61P 35/00, C07K 14/55, C07K 16/28, C07K 16/30, C07K 16/40, A61K 47/50
Applicant:
F. Hoffmann-La Roche AG
Agent:
Leah Noëmi Cueni, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature